Krilogy Financial’s Adient ADNT Stock Holding History

Krilogy Financial’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-8	Closed	–	–	156
2018 Q1	$0	Buy	+8	New	+$534	﹤0.01%	764

Other funds holding ADNT

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Krilogy Financial's ADNT Position: Q2 2018 in Review

Krilogy Financial sold out of Adient (ADNT) in Q2 2018, closing a stake of 8 shares.

Krilogy Financial first reported a position in ADNT in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 377 funds tracked by Wall St. Rank hold ADNT as of Q2 2018.

Krilogy Financial reported no remaining Adient position as of Q2 2018 after selling out during the quarter.
Krilogy Financial sold 8 Adient shares in Q2 2018.
Krilogy Financial first reported a position in Adient in Q1 2018 and held it in 1 quarter.
Krilogy Financial's Adient position peaked at $0 in Q1 2018.
377 funds tracked by Wall St. Rank held Adient as of Q2 2018.

Based on Krilogy Financial's 13F filing for Q2 2018, filed 15 Aug 2018.